H.P. Sleeboom

4.2k citations
21 papers · 1.8k indexed · 1 hit paper · h-index 12
Topics
Bone health and treatments (13 papers)Radiopharmaceutical Chemistry and Applications (6 papers)Cancer Diagnosis and Treatment (6 papers)

In The Last Decade

H.P. Sleeboom

21 papers receiving 1.7k citations

Hit Papers

Randomized, Double-Blind Study of Denosumab Versus Zoledr...20112026201620212011250500750

Peers

H.P. Sleeboom
Comparison fields: 5 of 73
  • Oncology 1.5k
  • Orthopedics and Sports Medicine 540
  • Radiology, Nuclear Medicine and Imaging 484
  • Pulmonary and Respiratory Medicine 405
  • Surgery 334
Replace María Eugenia Ibarrarán Viniegra with:
María Eugenia Ibarrarán Viniegra Argentina
Michael Rader United States
Clive Sinoff Canada
Joseph W. Leach United States
Yasuyuki Kojima Japan
W C Buijs Netherlands
Jennifer M. Grossman United States
B. Stein Australia
R Lahtinen Finland
Konstantinos Zervas Greece
H.P. Sleeboom relative to María Eugenia Ibarrarán Viniegra Argentina María Eugenia Ibarrarán Viniegra's profile →
Citations per field
00.5×1.5×
María Eugenia Ibarrarán Viniegra · 1×
Citations per year

Countries citing papers authored by H.P. Sleeboom

Since Specialization
Citations

This map shows the geographic impact of H.P. Sleeboom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.P. Sleeboom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.P. Sleeboom more than expected).

Fields of papers citing papers by H.P. Sleeboom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.P. Sleeboom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.P. Sleeboom. The network helps show where H.P. Sleeboom may publish in the future.

Co-authorship network of co-authors of H.P. Sleeboom

This figure shows the co-authorship network connecting the top 25 collaborators of H.P. Sleeboom. A scholar is included among the top collaborators of H.P. Sleeboom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.P. Sleeboom. H.P. Sleeboom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 22
3 3
4 7
5 38
6 18
7 258
8 3
9 108
10
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myelomabreakdown →
877
11 7
12 3
13 1
14 49
15 164
16 39
17 9
18 10
19 77
20 57

About H.P. Sleeboom

H.P. Sleeboom is a scholar working on Microbiology, Oncology and Orthopedics and Sports Medicine, having authored 21 papers that have together received 1.8k indexed citations. Recurring topics across this work include Bone health and treatments (13 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Orthopedics and Sports Medicine (540 citations), Oncology (1.5k citations) and Radiology, Nuclear Medicine and Imaging (484 citations). H.P. Sleeboom has collaborated with scholars based in Netherlands, Belgium and Portugal. Frequent co-authors include Roger von Moos, Luís Costa, Penella J. Woll, Vânia Hungria, Jianming Wang, Qi Jiang, Saroj Vadhan‐Raj, Vera Hirsh, Giorgio V. Scagliotti and Roger Dansey. Their work appears in journals such as Journal of Clinical Oncology, The American Journal of Medicine and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026